日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Breaking bandwidth limits in transformation optics with Brewster-enhanced metamaterials

利用布鲁斯特增强型超材料突破变换光学带宽限制

Hu, Xiaojun; Luo, Yu; Tang, Jingxin; Wang, Chun; Gao, Yuan; Zhang, Jingjing; Zhang, Yi; Ye, Dexin

Bioinformatics and machine learning approaches to explore the biomarkers in fatty acid degradation linked to osteoarthritis

利用生物信息学和机器学习方法探索与骨关节炎相关的脂肪酸降解生物标志物

Kovooru, Lohitesh; Zhang, Jingjing; Monni, Francesco Giuseppe; Dutta, Tanmoy; Gongye, Xiangdong; Asiedu, Bernice; Infelise, Patrizia; Barreby, Emelie; Jamialahmadi, Oveis; Mahlapuu, Margit; Mancina, Rosellina M; Romeo, Stefano; Li, Jian; Wei, Jinpeng; Wu, Hua; Hao, Haihu

A spatiotemporal atlas of cerebrovascular development in zebrafish

斑马鱼脑血管发育的时空图谱

Li, Xiaoyu; Ke, Shanshan; Wu, Chengchao; Wu, Mei; Ren, Yunfei; Wang, Zitong; Tang, Jialan; Zheng, Yuying; Mi, Da; Zhang, Jingjing

Bidirectional catalysts with dual-atom dynamic d-band centre modulation and support self-reconstruction for de/hydrogenation in MgH(2)/Mg

具有双原子动态d带中心调制和载体自重构的双向催化剂用于MgH(2)/Mg体系中的脱氢/加氢反应

Jin, Jinlong; Zhang, Jiyue; Zhang, Jingjing; Chen, Xiaowei; Qian, Heyi; Jia, Bohua; Liu, Jinghua; Han, Baoxin; Wang, Wentao; Yan, Xiaojun; Yan, Yigang; Shui, Jianglan; Huang, Jianmei

Engineering Metal-Organic-Framework-Based STING Nanoagonists for PROTAC-Enhanced Cancer Chemo-Metalloimmunotherapy

基于金属有机框架的STING纳米激动剂的工程化设计及其在PROTAC增强型癌症化疗-金属免疫疗法中的应用

Chen, Zhenzhen; Feng, Zhe; Wang, Siyuan; Zhang, Jingjing

Unraveling the Role of MoO(x) Clusters in Ternary Mo/Co(3)NiO(x) for Boosting Acidic Oxygen-Evolution Performance

揭示 MoO(x) 团簇在三元 Mo/Co(3)NiO(x) 中提升酸性析氧性能的作用

Zeng, Qiong; Zhang, Jingjing; Jadhav, Sarvesh Manoj; Wang, Yigui; Li, Zhiwen; Xiao, Dequan; Li, Gao

Synergistic Mn-MOF Activation of Pistol Ribozymes for Cancer Immunotherapy.

协同 Mn-MOF 激活手枪核酶用于癌症免疫治疗。

Zhao Ming, Qiao Shan, Bai Jie, Zhang Jingjing, Xi Zhiqin, Li Zhenzhen, Zhan Xuelin, Zhang Ying, Yu Xiaotong, Chen Yao, Liu Yijin

Brd4 BD1 Domain Antagonism of MS436 Preserves Blood-Brain Barrier Integrity via Rnf43/β-Catenin Signaling Pathway.

Brd4 BD1 结构域对 MS436 的拮抗作用通过 Rnf43/β-catenin 信号通路维持血脑屏障的完整性。

Li Chenxiao, Zhang Xiaochen, Xia Jiangwei, Liu Shuang, Du Yushan, Li Sihan, Zhang Shukui, Zhang Yong, Ji Fen, Jiao Jianwei, Zhang Jingjing

Intra-arterial peptide receptor radionuclide therapy (IA-PRRT) in patients with SSTR-expressing neuroendocrine neoplasms: short- and long-term safety and efficacy for up to 13 years

动脉内肽受体放射性核素治疗(IA-PRRT)治疗表达生长抑素受体(SSTR)的神经内分泌肿瘤患者:长达13年的短期和长期安全性和有效性

Zhang, Jingjing; Mensel, Birger; Baum, Richard P

Phase I dose-escalation study of [¹⁷⁷Lu]Lu-LNC1011, a long-circulating dansyl-modified PSMA theranostics, in metastatic castration-resistant prostate cancer

[¹⁷⁷Lu]Lu-LNC1011(一种长循环丹酰修饰的PSMA诊疗剂)治疗转移性去势抵抗性前列腺癌的I期剂量递增研究

Wang, Jiarou; Wang, Rongxi; Xiang, Jialin; Yang, Hongzhang; Zhao, Tianzhi; Guo, Feng; Liang, Yingkui; Zhu, Zhaohui; Zhang, Jingjing